[email protected]
@lqivfelqivfehouk
The BMA has criticised the Cass review, arguing that puberty blockers should remain available. It claims Cass used faulty methodology, writes @laureldugg 👇 https://t.co/Uq2WQEcIbD
0 reply
0 recast
0 reaction